Increased gamma-aminobutyric acid (GABA), homocarnosine and β-alanine in cerebrospinal fluid of patients treated with γ-vinyl GABA (4-amino-hex-5-enoic acid)
- 21 May 1981
- journal article
- Published by Elsevier BV in Life Sciences
- Vol. 28 (21), 2431-2439
- https://doi.org/10.1016/0024-3205(81)90511-7
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- The effect of γ-vinyl GABA and γ-acetylenic GABA on the concentration of homocarnosine in brain and CSF of the ratBrain Research, 1980
- Cerebrospinal fluid homocarnosine in Huntington's diseaseLife Sciences, 1980
- γ-AMINOBUTYRIC ACID IN HUMAN CEREBROSPINAL FLUID: NORMAL VALUESThe Lancet, 1979
- The relationship between GABA concentrations in brain and cerebrospinal fluidBrain Research, 1979
- GAMMA-AMINOBUTYRIC ACID AND THE SEARCH FOR NEW ANTICONVULSANT DRUGSThe Lancet, 1978
- 4‐Amino‐hex‐5‐enoic Acid, a Selective Catalytic Inhibitor of 4‐Aminobutyric‐Acid Aminotransferase in Mammalian BrainEuropean Journal of Biochemistry, 1977
- G.A.B.A. AND HUNTINGTON'S CHOREAThe Lancet, 1973
- SUSTAINED DRUG‐INDUCED ELEVATION OF BRAIN GABA IN THE RAT1Journal of Neurochemistry, 1973
- THE ROLE OF GABA METABOLISM IN THE CONVULSANT AND ANTICONVULSANT ACTIONS OF AMINOOXYACETIC ACIDJournal of Neurochemistry, 1973
- HOMOCARNOSINE IN HUMAN CEREBROSPINAL FLUID: AN AGE‐DEPENDENT PHENOMENON1Journal of Neurochemistry, 1968